5435242025-04-012025-06-305435242025-04-012025-06-30in-capmkt:OtherExpenses1Member5435242025-04-012025-06-30in-capmkt:OtherExpenses2Member5435242025-04-012025-06-30in-capmkt:OtherExpenses3Member5435242025-04-012025-06-30in-capmkt:OtherExpenses4Member5435242025-04-012025-06-30in-capmkt:OtherExpenses5Member5435242025-04-012025-06-30in-capmkt:OtherExpenses6Member5435242025-04-012025-06-30in-capmkt:OtherExpenses7Member5435242025-04-012025-06-30in-capmkt:OtherExpenses8Member5435242025-04-012025-06-30in-capmkt:OtherExpenses9Member5435242025-04-012025-06-30in-capmkt:OtherExpenses10Member5435242025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543524RAINBOWNOTLISTEDINE961O01016Rainbow Childrens Medicare LimitedMain BoardEquity2025-04-012026-03-312025-07-262025-07-21INRMillionsQuarterlyFirst quarterSingle segmentThe business of running multi-specialty pediatric and obstetrics and gynecology hospital.2025-07-2614:15:002025-07-2615:15:00Not applicable2025-04-012025-06-30UnauditedConsolidated3529290000200160000372945000047498000000516200000180780000341870000150188000030157100007137400000713740000171360000433000017569000005380500000000538050000-150000537900000534990000306000053478000031200001015520000105.275.27005.275.271 The above statement of unaudited consolidated financial results of Rainbow Childrens Medicare Limited the Company its subsidiaries and other consolidating entity the Company its subsidiaries and other consolidating entity together referred to as the Group which have been prepared in accordance with Indian Accounting Standards Ind AS prescribed under section 133 of Companies Act 2013 the Act read with relevant rules issued thereunder other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India SEBI were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 26 July 2025 The statutory auditors have carried out a limited review on the unaudited consolidated financial results and issued an unmodified report thereon <BR> <BR> 2 The consolidated figures for the fourth quarter ended 31 March 2025 are the balancing figures between published audited figures in respect of the full previous financial year and the published unaudited year to date figures up to the third quarter of the relevant financial year <BR> <BR> 3 Final dividend for the financial year 2024-25 of Rs 3 per Equity Share of Rs 10 each aggregating to Rs 304.66 million was approved by the shareholders at the 27th Annual General Meeting held on 05 July 2025 and the same was paid on 05 July 2025 <BR> <BR> 4 Pursuant to the resolutions passed by the Board of Directors on 09 February 2025 and by the Shareholders on 02 April 2025 the Company approved The Rainbow Childrens Medicare Limited Employee Stock Option Scheme 2025 ESOP 2025 in compliance with the SEBI Share Based Employee Benefits and Sweat Equity Regulations 2021 SEBI SBEB SE Regulations The ESOP 2025 is for issue of employee stock options to eligible employees which may result in an issuance of a maximum number of 1015000 Equity Shares Upon exercise and payment of the exercise price an option holder will be entitled to be allotted one equity share per employee stock option <BR> <BR> The Nomination and Remuneration Committee NRC of the Company in its meeting held on 26 July 2025 granted 140810 Stock options under the ESOP 2025 to its eligible employees which shall be exercisable into 140810 equity shares having face value of Rs10 each fully paid-up The Exercise price per stock option shall be determined at a discount of not more than 20 percentage on the latest available closing price of the Companys equity shares on the National Stock Exchange of India Limited being the stock exchange with the highest trading volume as on 25 July 2025 ie the trading day immediately preceding the date on which the grant of options was approved by the NRC The Stock options shall vest after the minimum vesting period of 1 year and not later than the maximum period of 10 years from the date of grant The vested Stock options shall be exercisable within a period of maximum of 2 years from the date of each vesting <BR> <BR> 5 Pursuant to the resolution passed by the Business Strategy and Investment Committee in its meeting held on 28 June 2025 the Company executed the Securities Subscription Agreement and Shareholders Agreement for acquisition of 76 percentage of fully diluted equity share capital and 100 percentage of Non-Convertible Redeemable Preference shares NCRPS of Ms Prashanthi Medicare Private Limited Prashanthi Hospital which operates 100 beds hospital at Warangal Telangana for an aggregate cash consideration of Rs 326 million On 01 July 2025 the Company completed the acquisition of 76 percentage of the fully diluted equity share capital and 100 percentage of the NCRPS of Prashanthi Hospital pursuant to which it became a subsidiary of the Company <BR> <BR> 6 The Group is principally engaged in a single business segment viz rendering medical and healthcare services Further the business operation of the group are concentrated in India and hence the group is considered to operate only in one geographical segment <BR> <BR> 7 The consolidated financial results for the quarter ended 30 June 2025 are available on the BSE Limited website URL wwwbseindiacom the National Stock Exchange of India Limited website URL wwwnseindiacom and on the Companys website URL wwwrainbowhospitalsin <BR> <BR> 8 The unaudited consolidated financial results include the financial results of Rainbow Childrens Medicare Limited and the financial results of its subsidiaries Rainbow C R O Private Limited Rainbow Fertility Private Limited Rainbow Women & Childrens Hospital Private Limited Rainbow Speciality Hospitals Private Limited Rosewalk Healthcare Private Limited Rainbow Childrens Hospital Private Limited and its other consolidating entity Rainbow Childrens Hospital FoundationProfessional fees to doctors917580000Canteen expenses67230000Contract wages103670000Housekeeping expenses22230000Power and fuel72920000Lab and investigations39820000Repairs and maintenance80310000Rates and taxes47040000Business promotion and advertisement51490000Other Expenses99590000Re-measurement (loss)/gain on defined benefit obligation-240000-240000-900000-150000